Development of bioartificial renal tubule devices with lifespan-extended human renal proximal tubular epithelial cells.

Abstract

BACKGROUND:

The bioartificial renal tubule device is a cell therapy system for renal failure. The major obstacle in the development of the bioartificial renal tubule device is the obtainment of a large number of viable renal tubule cells to seed on the inner surface of hollow fibers. Although our previous studies had used a transformed cell line, they may be dangerous for clinical uses. Therefore, different approaches to amplify renal proximal tubular epithelial cells (RPTEC) in culture without oncogenes, vectors and carcinogens have been required.

METHODS:

The limitation of the replicative lifespan of human RPTEC, which is ∼12 population doublings (PDs), was extended by invalidating messenger RNA of cell cycle-related genes with antisense oligonucleotide or small interfering RNA (siRNA).

RESULTS:

Periodic transfection of siRNA to a tumor suppressor p53 or a cyclin-dependent kinase inhibitor p16(INK4a) extended the lifespan by 33 and 63 PDs, respectively, in 3 months of culture. The siRNA-mediated lifespan extension was controllable because cell division ceased within 2 weeks after the transfection was discontinued. Expressions of γ-glutamyltransferase 1 and glucose transporter 1 were recovered in siRNA-transfected RPTEC cultured on porous membranes. Bioartificial renal tubule devices (0.8 m(2)) constructed with these cells showed reabsorption of water (122.3 ± 4.2 mL/30 min), sodium (18.1 ± 0.7 mEq/30 min) and glucose (121.7 ± 4.4 mg/30 min) after 1 week of circulation. Furthermore, β2-microglobulin and pentosidine were metabolized by RPTEC in mini-devices (65 cm(2)) within 48 h of circulation.

CONCLUSIONS:

These approaches enabled us to yield a high enough number of RPTEC for construction of bioartificial renal tubule devices repeatedly. Lifespan-extended RPTEC could recover their specific characteristics by culturing on porous membranes, and bioartificial renal tubule devices constructed with these cells showed good performances of reabsorption and metabolism.

SUMMARY:

A large number of human renal tubular cells required for construction of the bioartificial renal tubule device were prepared by extending the lifespan of the primary cells by invalidating mRNA of cell cycle-related genes. Constructed bioartificial renal tubule devices with lifespan-extended cells showed good performances of in vitro examination of reabsorption and metabolism. Requiring no oncogenes, vectors or cell cloning, the RNAi-mediated lifespan extension can help advance tissue-replacement therapy as well as basic research.

• Authors: Noriyuki Sanechika, Kaichiro Sawada, Yukio Usui, Kazuya Hanai, Takatoshi Kakuta, Hajime Suzuki, Genta Kanai, Satoshi Fujimura, Tun Aung Yokoyama, Masafumi Fukagawa, Toshiro Terachi, Akira Saito
• Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (Nephrol Dial Transplant) Vol. 26 Issue 9 Pg. 2761-9 (Sep 2011) ISSN: 1460-2385 [Electronic] England
• PMID: 21421594 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Cyclin-Dependent Kinase Inhibitor p16
• Glucose Transport Proteins, Facilitative
• Oligonucleotides, Antisense
• RNA, Messenger
• Tumor Suppressor Protein p53
• gamma-Glutamyltransferase

Topics

• Cells, Cultured
• Cyclin-Dependent Kinase Inhibitor p16 (antagonists & inhibitors, genetics, metabolism)
• Epithelial Cells (cytology, metabolism)
• Glucose Transport Proteins, Facilitative (genetics, metabolism)
• Hemofiltration (instrumentation)
• Humans
• Kidney Tubules, Proximal (cytology, metabolism)
• Kidneys, Artificial
• Oligonucleotides, Antisense (pharmacology)
• Porosity
• RNA, Messenger (genetics)
• Real-Time Polymerase Chain Reaction
• Tumor Suppressor Protein p53 (antagonists & inhibitors, genetics, metabolism)
• gamma-Glutamyltransferase (genetics, metabolism)